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Abstract 35 
Objectives: The aim of this study was to identify themes that determine health-related 36 
quality of life (HRQoL) in patients with carotid artery stenosis and identify the patient-37 
reported outcome measures that best cover the identified themes.  38 
Methods: A systematic review of the main six databases from inception to September 2018 39 
was undertaken to identify primary qualitative studies reporting on the HRQoL of patients 40 
with carotid artery stenosis.  Quality of studies was assessed using the CASP criteria. 41 
Findings from the included studies were analysed using Framework Analysis methodology. 42 
The identified themes were mapped against the items/domains from the patient-reported 43 
outcome measures used previously in patients with carotid artery stenosis.  44 
Results: The systematic review identified four papers that fulfilled the inclusion criteria. The 45 
included papers reported the views of sixty-two patients with symptomatic carotid artery 46 
stenosis; twenty-four of the patients were awaiting assessment for intervention, twenty-six 47 
had carotid endarterectomy and twelve were turned down for intervention and received best 48 
medical therapy. The overall quality of the included studies was good based on CASP 49 
criteria.  Framework Analysis identified sixteen themes that were divided into six main 50 
domains: anxiety, impact on physical activity, effect on independence, impact on personal 51 
roles, psychological impact and symptoms. The best fit generic and disease specific PROMs 52 
were the Short-Form 36 (SF-36 ®) and the Carotid Stenosis Specific Outcome Measure 53 
(CSSOM) respectively. None of the PROMs covered all the themes identified in the 54 
qualitative systematic review.  55 
Conclusion: The findings from the review identified the important themes that affect patients 56 
with carotid stenosis disease.  The current generic and disease specific patient-reported 57 
outcome measures do not cover all themes that impact the HRQoL of patients suffering with 58 
this disease. The proposed themes can be used to develop a new disease specific PROMs 59 
to measure HRQoL.  60 
Key Points 61 
Carotid artery disease is the main cause of stroke; some patients with this disease 62 
can benefit from surgical intervention to reduce the risk of future stroke. 63 
 64 
 65 
Understanding and measuring quality of life in these patients can guide intervention 66 
decisions. 67 
 68 
This systematic review provides detailed overview of the impact of this disease on 69 
quality of life 70 
 71 
Introduction 72 
 73 
Carotid artery stenosis (CAS) is a major cause of stroke, accounting for about 20% of all 74 
cases (1-2). It is caused by either carotid artery lesion thrombosis or embolism this lesion.   75 
Patients with CAS can be asymptomatic or present with transient ischaemic attack (TIA) or 76 
stroke. Evidence shows that patients who present with disabling stroke with previous 77 
evidence of CAS can benefit from preventive procedures including carotid endarterectomy 78 
(CEA) and stenting (3-10); however, these procedures are not risk free and can be 79 
complicated with perioperative stroke.  The symptoms and the uncertainty of outcome can 80 
impact the daily living of patients with CAS. Therefore, several clinical studies that 81 
investigated the efficacy and safety of different preventative interventions used patient-82 
reported outcome measures (PROMs) to investigate the impact of the disease and treatment 83 
on health-related quality of life (HRQoL). However, due to a lack of validated PROMs they 84 
either used generic PROMs (11-14) or developed and used questionnaires without validation 85 
(14).  86 
Patients presenting with symptomatic and asymptomatic CAS need support to choose the 87 
best treatment strategy to help reduce their risk of stroke and improve their HRQoL. Patients' 88 
experience of disease and impact of treatment is a major indicator of quality and it is only 89 
through better understanding of the impact of the disease on HRQoL that PROMs can be 90 
developed. It is argued that PROMs, when designed carefully (e.g. based on input from 91 
patieQWV¶ H[SHULHQFHV), can measure the issues of most importance to patients and any 92 
changes to their HRQoL because of the disease or as consequence of the treatment they 93 
may have received (15). 94 
 95 
The aim of this study was to systematically review the qualitative evidence to identify the 96 
impact of CA6DQGWUHDWPHQWSDWKZD\RQSDWLHQWV¶HRQoL. The identified themes were then 97 
mapped against the items and domains from the generic and disease specific PROMs we 98 
had previously identified (16,17). The mapping was done to find the PROMs that captured 99 
the most important issues to patients with CAS.  100 
Method 101 
 102 
The systematic review aimed to identify all primary qualitative research studies that 103 
investigated the impact of CAS on HRQoL. The inclusion criteria included any patients with 104 
CAS and any studies with undefined population were excluded. For further information 105 
regarding the inclusion and exclusion criteria refer to table 1.  106 
This systematic review was undertaken and reported in accordance with the general 107 
principles recommended in the Preferred Reporting Items for Systematic Reviews and Meta-108 
Analyses (PRISMA) statement. In accordance with the study protocol (18), searches were 109 
conducted from inception up to April 2017 and further updated to September 2018, in the 110 
following bibliographic databases; CINAHL via EBSCO, Medline and Medline in Process via 111 
Ovid, Embase via Ovid, PsycINFO via Ovid, Social Science Citation Index/ Science Citation 112 
Index via Web of Science (Thomson Reuters) and Proquest dissertations and theses. No 113 
language or date constraints were applied.  114 
 115 
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 117 
 118 
 119 
 120 
 121 
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 125 
 126 
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 129 
 130 
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 134 
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 138 
 139 
 140 
 141 
 142 
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 144 
 145 
Table 1:  Summary of the inclusion and exclusion criteria 146 
 147 
 148 
 149 
 150 
 151 
 152 
 153 
 154 
 155 
 156 
 157 
 158 
 159 
 160 
Inclusion Exclusion 
3DWLHQWV¶H[SHULHQFHRIOLYLQJZLWKFDURWLG
artery stenosis and its impact on their health-
related quality of life. 
Studies not in English 
Studies with participants under 16 
years of age 
A defined population of participants with a 
diagnosis of carotid artery stenosis (CAS) 
who need, have had or are undergoing 
surgical treatment. Participants undergoing 
treatment for stroke or transient ischaemic 
attack (TIA) secondary to a diagnosis of 
CAS. 
Patients with Stroke or TIA not 
related to CAD 
Studies that include semi-structured 
interviews, descriptions, focus groups either 
as stand-alone studies or embedded in a 
quantitative study. Must include both data 
collection and data analysis 
Quantitative studies with no 
primary qualitative data reported 
Published or unpublished; 
Full-text or structured abstract with all 
relevant information 
Full-text or structured abstract with 
incomplete or unclear evidence 
 161 
The search strategy combined condition terms, terms for patient views and terms for 162 
qualitative studies (which augmented a qualitative study filter) (19). Further details of the 163 
search strategy are provided in Appendix 1 (supporting information).  164 
 165 
Study selection 166 
The search results were uploaded into Endnote X8 Thomson Reuters, Philadelphia, 167 
USA), two reviewers (AA, AH) independently screened the titles for inclusion and exclusion 168 
in accordance with the set criteria in the protocol. All titles were examined, and any citations 169 
that clearly did not meet the inclusion criteria (for example mixed population, quantitative 170 
PROMs data) were excluded. For included titles, abstracts were read and for the included 171 
abstracts, full-text articles were obtained.  172 
 173 
Quality assessment 174 
The Critical Appraisal Skills Program (CASP) qualitative checklist instrument was used to 175 
examine the methodological quality of the included studies (20). This was selected for its 176 
appropriateness as it is commonly used in qualitative reviews of evidence (21). Two of the 177 
authors (AA, AH) independently examined the quality of each study and any inconsistencies 178 
were resolved by discussion or involving a third author (GJ).   179 
 180 
 181 
Data extraction and analysis 182 
The data on authors, year of publication, country of study, number of participants, research 183 
aims, methods of recruitment, method of data collection, key results and analysis were 184 
extracted and tabulated for all the included studies by the first author.  The included papers 185 
were uploaded into the qualitative data analysis software NVIvo10 (QSR International, 186 
Doncaster, Victoria, Australia) and the primary and secondary text (patient quotes reported 187 
in the articles and themes), were analysed. The inductive process of framework analysis was 188 
used for the qualitative evidence synthesis. In another systematic review (17); the PROMs 189 
used for this condition were examined for their validity; their conceptual domains were used 190 
to give a basis for the qualitative data synthesis (22). The first stage of the framework 191 
analysis was reading all the included papers and identifying common themes from within and 192 
across the articles. The second stage involved establishing a thematic framework by 193 
creating a list of the main themes based on the domains of validated PROMs and common 194 
themes in the identified papers. In the third stage the thematic framework was applied to all 195 
the primary and secondary data. In the final stage themes were examined for their 196 
conceptual similarities and differences. The second author (AH) checked all the themes that 197 
were identified and differences in conceptualization were discussed and adjusted involving a 198 
third senior author (GJ). 199 
 200 
Triangulation of PROMs items with qualitative themes 201 
A triangulation of evidence was performed to examine how the items within generic and 202 
disease specific PROMs corresponded to themes from the qualitative review (23,24).  The 203 
items from generic and disease specific PROMs used in patients with CAS (17) were 204 
examined in detail. The items from these instruments were mapped against the themes 205 
identified, and two researchers (AA, AH) reviewed both the themes from the qualitative 206 
review and the items/ from each PROM to evaluate whether the concepts were the same 207 
(agreement), offered similar concepts (partial agreement) or were not present (silence). The 208 
aim was to identify whether any of the instruments covered the issues that are important to 209 
patients with carotid artery disease.  210 
Results 211 
 212 
The database searches identified 1,095 citations; after removing duplicates, 859 titles were 213 
assessed and subsequently fifteen full-text papers were reviewed in detail. Finally, only four 214 
papers fulfilled the inclusion criteria and were included in the qualitative evidence synthesis 215 
(Please see PRISMA chart (Figure 1)). The studies included in the qualitative synthesis are 216 
summarized in table 2.  217 
 218 
 219 
Table 2. Qualitative studies exploring living with carotid artery stenosis 220 
 221 
Author 
(Year) 
Country Research 
Design 
Method of 
Analysis 
Age 
(years) 
Sample Diagnosis 
/Treatment 
Study Aims and 
Objectives 
Gibson 
(2002) 
(25) 
UK Qualitative 
semi-
structured 
interviews 
Grounded 
Theory 
Age, 
mean 
70.9 
(50-79) 
 
6 
Participants 
 
 
Male (%): 
50 
Symptomatic 
carotid 
stenosis 
 
Medical 
management: 
1 
 
Post CEA: 5  
 
Explore ways in 
which patients 
comprehend and live 
with risk of CEA or 
medical 
management only for 
carotid stenosis. 
Halin et 
al. 
(2002) 
(26) 
Sweden Mixed 
methods 
including a 
qualitative 
component 
using 
semi-
structured 
interviews  
Thematic 
analysis 
Age, 
mean 
71 (56-
80) 
 
20 
Participants 
Male (%): 
60 
Symptomatic 
carotid 
stenosis 
Medical 
management, 
no 
intervention: 1 
Post CEA: 11 
Pre-CEA or 
Stent: 8 
Assess quality of life 
of patients with 
carotid artery 
stenosis 
Gibson 
& 
Watkins 
(2012) 
(27) 
UK In-depth 
interviews 
 
Grounded 
Theory 
Age, 
Mean 
71.6(50-
80) 
16 
Participants  
Male (%): 
65 
Symptomatic 
carotid 
stenosis 
 
Explore the lived 
experience of 
patients with TIA 
secondary of carotid 
stenosis 
Gibson 
& 
Watkins 
(2013) 
(28) 
UK In-depth     
semi-
structured 
interviews  
 
Thematic 
analysis 
Age, 
mean 
70.2 
(50-80) 
 
20 
Participants 
Male (%): 
65 
 
TIA/Recovered 
stroke 
Post CEA: 10 
 
Medical 
management: 
10 
 
To examine the use 
of formal and 
informal knowledge 
by patients in making 
decisions about 
(CEA) and medical 
WUHDWPHQWDIWHU7,$»
recovered stroke 
caused by carotid 
stenosis  
 
Abbreviations: Carotid revascularisation Enarterectomy (CEA), Transient ischaemic attack (TIA) 
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 Figure 1. PRISMA Diagram: CS Qualitative Systematic Review   231 
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 274 
Records identified through 
database searching  
(n = 1091 ) 
S
cr
e
e
n
in
g
 
In
cl
u
d
e
d
 
E
li
g
ib
il
it
y
 
Id
e
n
ti
fi
ca
ti
o
n
 
Additional records identified 
through other sources  
(n = 4) 
Records after duplicates removed  
(n = 874) 
Records excluded  
(n = 859) 
Full-text articles assessed 
for eligibility  
(n = 15) 
Full-text articles excluded, 
with reasons  
(n = 5) 
 
Non-qualitative study  
(n = 4) 
Wrong population 
(n =2) 
 
 
Studies included in 
qualitative synthesis  
(n = 4) 
 275 
 276 
Three of the included studies were from the UK (25, 27-28) and one from Sweden (26). The 277 
studies were published between 2002 and 2013; the age of patients with carotid artery 278 
disease in the included studies ranged from 50-80 years, and the percentage of male 279 
participants was 50-65%. The included studies reported the views of sixty-two patients with 280 
twenty-four of the patients awaiting assessment for surgery, twenty-six had surgery and 281 
twelve were turned down for intervention and received best medical therapy.  282 
 283 
Quality assessment  284 
The quality of the included studies was assessed independently by two authors (AA, AH) 285 
using the CASP checklist (10) for qualitative studies, any disagreement on the final score 286 
was resolved through discussion and/or involving a third senior author (GJ).  The overall 287 
quality of the included studies was good, DQGDOOWKHVWXGLHVVFRUHG³\HV´IRUDOPRVWDOOWKH288 
FULWHULDVHWLQWKH&$63FKHFNOLVW2QO\RQHVWXG\VFRUHGµFDQ¶WWHOO¶on the rigour of the data 289 
analysis (25). For detail on the quality of the included studies see table 3. 290 
 291 
 292 
 293 
 294 
 295 
 296 
 297 
 298 
 299 
Table 3: CASP checklist final score for included studies 300 
Paper CASP Quality Appraisal 
 1. Was 
there a 
clear 
statement 
of the 
aims? 
2. Is a 
qualitative 
methodology 
appropriate? 
3. Was the 
research 
design 
appropriate 
to address 
the aims of 
the 
project? 
4. Was the 
recruitment 
strategy 
appropriate 
to the aims 
of the 
research? 
5. Was 
the data 
collected 
in a way 
that 
addresses 
the 
research 
issue? 
6. Has the 
relationship 
between 
researcher 
and 
participants 
been 
adequately 
considered? 
 
7. Have 
ethical issues 
been taken 
into 
consideration? 
8. Was the 
data 
analysis 
sufficiently 
rigorous? 
9. Is 
there a 
clear 
statement 
of 
findings? 
10. How 
valuable 
is the 
research? 
Gibson 
2002 
(25) 
 
9 
 
9 
 
9 
 
9 
 
9 
 
9 
 
9 
 
? 
 
9 
 
9 
Hallin et 
al.  
2002 
(26) 
9 9 9 9 9 9 9 9 9 9 
Gibson 
& 
Watkins  
2012 
(26) 
 
9 
 
9 
 
9 
 
9 
 
9 
 
9 
 
9 
 
9 
 
9 
 
9 
Gibson 
& 
Watkin  
2013 
(28) 
 
9 
 
9 
 
9 
 
9 
 
9 
 
9 
 
9 
 
9 
 
9 
 
9 
Analysis 301 
The Framework Analysis of the primary and secondary data of the included papers identified 302 
sixteen themes. These were divided into five main domains comprising; anxiety, impact on 303 
personal roles, effect on independence, psychological impact and symptoms. Please see 304 
Table 4 for further details.  305 
 306 
 307 
 308 
Table 4: Themes identified from qualitative research studies of patients with carotid 309 
artery stenosis. 310 
 311 
 312 
 313 
 314 
 315 
 316 
 317 
 318 
 319 
Themes (Domains in bold 
font) 
 
Gibson 
(2002) 
Halin et 
al. 
(2002) 
Gibson & 
Watkins 
(2012) 
Gibson & 
Watkins 
(2013) 
 
Anxiety 
   
 
Fear of stroke ¥ ¥ ¥ ¥ 
Fear of becoming a burden  ¥ ¥ ¥ ¥ 
Fear of operation  ¥ ¥ 
 
¥ 
Uncertainty about future ¥ ¥ ¥ ¥ 
Impact on personal roles & 
activities  ¥ ¥ ¥ ¥ 
Effect on independence  ¥ ¥ ¥ ¥ 
Psychological impact  
   
 
Happiness  ¥ 
 
¥ ¥ 
Health perception ¥ 
  
 
Symptoms  
    
Weakness   ¥  
Numbness or loss of sensation   ¥  
Loss of ability to speak    ¥  
Loss of vision    ¥  
Cognitive function   ¥  
Duration of symptoms   ¥  
Neck stiffness  ¥  ¥  
 320 
Anxiety 321 
 322 
The anxiety domain had several themes including fear of stroke, fear of becoming a burden, 323 
worry and uncertainty and fear from consequences of the operation. These four themes 324 
were grouped together because of overlapping. The impact of anxiety on daily living of 325 
patients suffering with CAS featured in all four studies. Patients experiencing symptoms of 326 
transient ischaemic attack (TIA) secondary to CAS expressed concern about fear of stroke, 327 
patients said: 328 
³,
PDIUDLGRIKDYLQJDVWURNHDQGWKHQEHFRPLQJSDUDO\VHG´ (Pre-operative patient, 329 
age not reported) (26) 330 
³,¶GEHZRUU\LQJDORW\HVZRQGHULQJZKHQRUZKHUHRUKRZLWVWURNHZDVJRLQJWR331 
KDSSHQ«LWZRXOGEHLQWKHEDFNRIP\PLQG«ZKLFKWDNHVVRPHRIWKHSOHDVXUHRXWof life.´ 332 
(Patient experienced TIA ±before CEA) (27) 333 
³:HOO,ZRXOGQ¶WOLNHWREHKHUHDQGKDYHRQHVWURNHRQP\RZQ´Patient 334 
experienced TIA ±before CEA) (25) 335 
 336 
Two of the major causes for worry from having symptomatic CAS that can cause stroke were 337 
uncertainty and fear of becoming a burden. Participants in the included studies reported 338 
feeling that their life was put on hold and many were worried that a disabling stroke may 339 
make them a burden on others including their family members.  340 
 ³,W¶VWKHXQNQRZQLVQ¶WLWWKDW¶VZKDWPDNHV\RXIHDUIXO\RXGRQ¶WNQRZZKDW¶VJRLQJ341 
WRKDSSHQ´SDWLHQWDIWHUWKH&($UHIOHFWLQJRQH[SHULHQFHVSULRUWRWKHVXUJHU\ (25) 342 
³,
PDIUDLGRIEHFRPLQJGHSHQGHQWRQFDUH´ (Pre-operative patient) (26) 343 
 344 
The uncertainty about the future and fear of sudden stroke was affecting patients treated 345 
with best medical therapy when compared to patients treated with preventive procedures 346 
such as CEA or stenting (27).  Another source of anxiety was the worry from complications 347 
RIVXUJHU\LQFOXGLQJGHDWKRUVWURNH0DQ\SDWLHQWV¶SHUFHSWLRQVDERXWWKHULVNRIVWURNHIURP348 
the preventive procedures were disproportionate (25), some patients thought that their risk of 349 
stroke from the surgery was 50% and this higher than the 2% reported by clinical studies 350 
(3,4). Furthermore, many patients had an inaccurate recall of the risks of treatment options 351 
offered to them (25). 352 
³LIVRPHERG\WHOOV\RXWKHUH¶VDFKDQFHRIKDYLQJDVWURNHZLWKRXWVXUJHU\353 
WKDW¶VLQ\RXUPLQGDOOWKHWLPH´ (patient after the CEA reflecting on experiences prior to the 354 
surgery) (25) 355 
 356 
³<RX¶UHGDPQHGLI\RXGRDQGGDPQHGLI\RXGRQ¶W,PHDQ,¶GKDYHDVWURNHLI,GLGQ¶W357 
KDYHLWDQG,PLJKWKDYHWKHVWURNHXQGHUWKHRSHUDWLRQ´ (Patient experienced TIA ±before 358 
CEA) (25) 359 
 360 
Patients with successful revascularisation reported improved psychological wellbeing and 361 
felt that they could move on with their lives compared to the time prior to their procedure 362 
when they felt that their daily livings were overshadowed by the worry associated with the 363 
CAS diagnosis and possible stroke (25).  364 
,¶PDKDSSLHUSHUVRQSK\VLFDOO\DQGHPRWLRQDOO\´(patient after the CEA reflecting on 365 
experiences prior to the surgery) (25) 366 
Impact on Personal Roles & Activities  367 
 368 
Some participants in the included studies described the onset of symptomatic CAS to have 369 
put a hold on their life and without the preventative surgery, they would have not been able 370 
to carry on with their personal roles and daily activities (25). Some patients took many 371 
measures in their daily living to avoid activities that they perceived may increase their risk of 372 
further TIA or major stroke. For instance, some patients made changes to their diet (26). 373 
One patient said: 374 
 375 
³,¶GKDYHEHHQZRUULHGDERXWKDYLQJDVWURNHLWFXUWDLOHGP\DFWLYLWLHV´(Post-376 
operative patient) (26) 377 
 378 
The anxiety associated with further TIA or strokes as well as residual symptoms of strokes 379 
had an impact on the physical functioning of the patients (25).Patients also suggested that 380 
the symptomatic CAS causing TIA dramatically changed their perception about their physical 381 
health, Furthermore, attitude of family and friend reinforced this view of diminished physical 382 
function (27). 383 
 ³,¶YHDOZD\VNHSWP\KHDOWK«WKLVKDVDEVROXWHO\VKDWWHUHGPH´ (Patient experienced 384 
TIA) (27) 385 
³\RX¶UHQRWDV¿WDV\RXWKRXJKW\RXZHUHHYHU\ERG\¶VDOZD\VWHOOLQJPHWREH386 
FDUHIXODQGKDYHDUHVW«SHRSOHDURXQGPHKDYHVRUWRIFRQYLQFHGPHWKDW,¶PDELW387 
IUDJLOH«´ (Patient experienced TIA) (27). 388 
Effect on Independence    389 
 390 
All the included studies reported that patients suffering with CAS felt that their social life and 391 
independence were compromised because of the disease and potential consequences. 392 
Patients expressed concerns about the impact of the disease and possible consequences of 393 
on their independence.  394 
³I'm afraid of becoming paralysed and dependent on care´(patient reporting after 395 
surgery) (25) 396 
  397 
 ³,¶PHQMR\LQJOLIHDQG,ZDQWLWWRJRRQZLWKRXWKDYLQJDVWURNH´(patient reporting 398 
after surgery) (28) 399 
 400 
 401 
Psychological Impact  402 
 403 
Patients suffered with issues related to their health perception; the diagnosis had adverse 404 
consequences for many patients; with some reporting that they felt their daily life is being 405 
shattered with the new diagnosis (27).  406 
Some patients developed low mood when they understood the risks associated with their 407 
disease, however, on the other hand, patients who had the operation and did not experience 408 
any complications reported that they felt happier emotionally because of dealing with a 409 
potentially significant disease that made them felt unhappy (25, 27-28). One patient 410 
reported: 411 
 ³,¶PDKDSSLHUSHUVRQSK\VLFDOO\DQGHPRWLRQDOO\´ (patient reporting after 412 
surgery) (25) 413 
 414 
Symptoms  415 
 416 
The symptomatic outcomes that were reported by the patients could be divided broadly into 417 
two main groups: symptoms associated with TIA and post-intervention symptoms. Patients 418 
experiencing TIA reported classical symptoms including loss of sensation, weakness, 419 
temporary loss of ability to speak and loss of vision (27).  420 
 ³,FRXOGQ¶WSLFNDQ\WKLQJXSDWDOO,KDGJUHDWGLI¿FXOW\LQXVLQJWKHknife and 421 
IRUN«DQGWKHQVXGGHQO\LWFDPHEDFN´3DWLHQWUHSRUWLQJ7,$V\PSWRPV(27) 422 
³,MXVWWKRXJKWD¿OPKDGFRPHRYHUP\H\H´(Patient reporting TIA symptoms) (27) 423 
 424 
Patients described symptoms of neck pain and discomfort at the site of operation to treat 425 
CAS following CEA (25).  426 
 ³«GLGIHHOEHWWHUDSDUWIURPUHVLGXDOPLQRUGLVFRPIRUWIURPVXUJLFDOLQFLVLRQ427 
SDLQDQGQHFNVWLIIQHVV´ (patient reporting after surgery) (25) 428 
 429 
Lastly, some patients described loss of cognitive function that was noticeable by their family 430 
and caused concern for the patient (25). 431 
 ³,KDYHGLIILFXOWLHVWDNLQJSDUWLQDGYDQFHGGLVFXVVLRQV

(patient with carotid artery 432 
stenosis) (25) 433 
Triangulation 434 
The identified themes were compared to items from PROMs that were identified in a recent 435 
study (17). These PROMs include the carotid artery disease quality of life questionnaire 436 
developed by the Carotid revascularisation Enarterectomy vs. Stenting Trial group (CREST 437 
Randomised controlled trial), Carotid Stenosis Specific Outcome Measure developed by 438 
Ivanova et al (28), Dizziness Handicap Inventory (DHI), Hospital Anxiety and Depression 439 
Scale (HADS), EuroQoL-5D (EQ-5D), and the Short-Form 36 (SF-36 ®).  Two reviewers 440 
(AA, AH) examined the overlap between the themes in the qualitative review and items in 441 
the PROMs. When there was complete overlap between the theme and an item in an 442 
instrument an agreement score (+) was awarded; however, when the theme is covered in a  443 
general question a partial agreement score was awarded (+/-).  444 
 445 
 446 
Table 5: Themes identified from the qualitative review mapped against items of 447 
validated PROMs 448 
 449 
 450 
 451 
Themes CREST 
trial 
PROMs 
CSSOM DHI HADS EQ-5D SF-36 
Anxiety  - + +/- + + + 
Fear of stroke - - - - - - 
Fear of becoming a burden  - + - - - - 
Fear of operation  - - - - - - 
Uncertainty about future - - - - - - 
Impact on personal roles & 
activities - + + +/- - - 
Effect on Independence  - - +/- - - - 
Psychological impact  - + + + +/- + 
Happiness  - + + + - + 
Health Perception  - - - - - - 
Symptoms +/- + + - - - 
Weakness - + +/- - - - 
Numbness or loss of sensation - + - - - - 
Loss of ability to speak  - - - - - - 
Loss of vision  - + - - - - 
Cognitive function  - + - - - - 
Duration of symptoms - - - - - - 
Neck Stiffness  + + - - - - 
Abbreviations: Carotid revascularisation Enarterectomy vs. Stenting Trial (CREST Randomised controlled trial), 
Dizziness Handicap Inventory (DHI), Hospital Anxiety and Depression Scale (HADS), EuroQoL-5D (EQ-5D), and Medical 
outcomes study 36-item short form (SF-36 ®), Carotid Stenosis Specific Outcome Measure (CSSOM). 
Scores: íVLOHQFHíSDUWLDODJUHHPHQW +, agreement. 
 
None of the identified PROMs covered important HRQoL themes such as fear of stroke or 452 
fear from the operation as well as uncertainty about future caused by the diagnosis of the 453 
disease. Many of the symptoms described in the qualitative evidence synthesis of this study 454 
were not included in the PROMs used previously. The generic PROM that captured most of 455 
the important issues for patients with CAS was the SF-36 ® and the disease specific PROM 456 
was the PROMs for carotid artery disease developed by Ivanova et al (28). However, both 457 
PROMs did not cover all the themes identified in this review. For further details on the results 458 
of triangulation see table 5. 459 
 460 
Discussion 461 
 462 
We identified six domains that impacted upon the HRQoL of patients with CAS throughout 463 
their care pathway. These include anxiety, impact of the disease on personal roles/ activities, 464 
impact on physical functioning, impact on social functioning, psychological impact, and 465 
symptoms associated with it.  466 
The HRQoL of patients with CAS undergoing either revascularisation or best medical 467 
therapy have only been measured using generic PROMs, anxiety specific PROMs and 468 
questionnaires developed by clinicians with no validation (RCT) (5-11).  A single RCT 469 
attempted to develop a disease specific PROM for patients with CAS (11) however, the 470 
instrument was made of the six items suggested by clinicians and, more importantly, patients 471 
were not consulted.  Furthermore, there was no further validation for this PROM.  472 
Clinical outcomes such as 30-days mortality, stroke-free survival, and re-stenosis have been 473 
used to compare the efficacy of surgical, radiological and medical therapies for patients with 474 
CAS. These are important outcomes, however, HRQoL, when measured using a validated 475 
PROM can provide comprehensive data about the impact of different therapies. The themes 476 
from this review can be used to develop a more tailored PROM that can be used in routine 477 
clinical practice both to inform discussion between patients and clinicians, as well as, a 478 
quality measure of the carotid revascularisation service.  479 
 480 
One of the strengths of this study is that the qualitative review included patients at different 481 
stages of their care pathway including sixty-two patients with symptomatic carotid artery 482 
stenosis; twenty-four of the patients waiting for to meet a clinician to decide whether they are 483 
suitable for surgery or stenting, twenty-six patients had carotid endarterectomy with no 484 
complications and twelve patients turned down for surgical or interventional radiology 485 
procedures. This review used the evidence from an earlier systematic review (11) by the 486 
same group to evaluate the validity of PROMs used in patients with CAS.  This earlier 487 
systematic review was performed to examine the psychometric validation evidence for 488 
PROMs used in patients with CAS. In the triangulation section of this study the themes from 489 
the qualitative review were mapped against the items from the generic and disease specific 490 
CAS PROMs that were identified.  491 
 492 
The main limitation of this study is that it relies on the primary and secondary data of existing 493 
studies. The patients sampled in one of the studies only included patients with CAS waiting 494 
for operation (27); whereas, the other three studies included patients on best medical 495 
therapy for CAS as well as patients waiting for preventive surgery and patients following their 496 
operation.  Furthermore, the included studies beside investigating aspects of HRQOL also 497 
examined issues such as decision making about management that were not related to 498 
HRQoL. Additionally, few patients who were treated with best medical therapy or turned 499 
down for revascularisation were included in any of the studies. The included papers did not 500 
distinguish clearly between patients with resolved stroke symptoms and TIA. Some papers 501 
mentioned important themes such as denial of diagnosis and depression but failed to report 502 
any primary evidence to support these themes (27, 28). 503 
 504 
Amongst some clinical academic circles HRQoL has confusingly come to be known as 505 
anything which is not clinical (30).  However, this study demonstrates that patients with CAS 506 
experience distress related to diagnosis and the risks associated with the intervention. 507 
These have an adverse impact on their wellbeing and should be taken into consideration by 508 
the clinician. The review identified anxiety to be an important domain that impacts the 509 
HRQoL of patients with CAS and this is related to fear of stroke, uncertainty about future, 510 
fear of becoming a burden on others and fear of operation. Carotid artery disease also had 511 
an impact of on the patient independence, the personal functioning and beyond anxiety had 512 
a further psychological effect on patients. 513 
This systematic review of the qualitative evidence combine all the relevant data concerning 514 
the impact of CAS and its treatments on the patients. One of the strongest finding of this 515 
study is that none of the generic and disease specific PROMs covered all the important 516 
issues for CAS patients revealed by this qualitative systematic review.  517 
Conclusions 518 
 519 
The identified themes that impact the HRQoL of patients with CAS can be used to develop a 520 
disease-specific PROM. Our group designed this instrument and currently validating this 521 
PROM in an extensive survey of patients with CAS.  The aim is to perform a factor analysis 522 
as well as further psychometric studies to ensure the PROM's validity, reliability, and 523 
responsiveness.  524 
 525 
³'DWD$YDLODELOLW\6WDWHPHQW´ 526 
The analysis data cannot be shared since some of the papers included in the systematic 527 
review have copy rights and these prohibit publishing them in other journals but allow 528 
researchers to use them for secondary analysis. These papers were uploaded into the 529 
software in which we performed the analysis. Supplementary materials are included 530 
regarding the search strategy and analysis.  531 
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